Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marco Ferrone, M.D.

Co-Author

This page shows the publications co-authored by Marco Ferrone and John Chi.
Connection Strength

0.555
  1. Design of the prospective observational study of spinal metastasis treatment (POST). Spine J. 2020 04; 20(4):572-579.
    View in: PubMed
    Score: 0.211
  2. Characteristics of Patients and Treatment Recommendations from a Multidisciplinary Spinal Tumor Program. Palliat Med Rep. 2020; 1(1):143-148.
    View in: PubMed
    Score: 0.055
  3. Prospective validation of a clinical prediction score for survival in patients with spinal metastases: the New England Spinal Metastasis Score. Spine J. 2021 01; 21(1):28-36.
    View in: PubMed
    Score: 0.054
  4. Non-operative management of spinal metastases: A prognostic model for failure. Clin Neurol Neurosurg. 2020 01; 188:105574.
    View in: PubMed
    Score: 0.053
  5. Ambulatory status after surgical and nonsurgical treatment for spinal metastasis. Cancer. 2019 08 01; 125(15):2631-2637.
    View in: PubMed
    Score: 0.051
  6. Assessing the utility of the spinal instability neoplastic score (SINS) to predict fracture after conventional radiation therapy (RT) for spinal metastases. Pract Radiat Oncol. 2018 Sep - Oct; 8(5):e285-e294.
    View in: PubMed
    Score: 0.047
  7. Assessing the utility of a prognostication model to predict 1-year mortality in patients undergoing radiation therapy for spinal metastases. Spine J. 2018 06; 18(6):935-940.
    View in: PubMed
    Score: 0.046
  8. Early Surgical Outcomes of En Bloc Resection Requiring Vertebrectomy for Malignancy Invading the Thoracic Spine. Ann Thorac Surg. 2016 Jan; 101(1):231-6; discussion 236-7.
    View in: PubMed
    Score: 0.039
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.